Albumin and heparin multilayer coatings for blood-contacting medical devices
- 19 May 2000
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research
- Vol. 51 (2), 249-257
- https://doi.org/10.1002/(sici)1097-4636(200008)51:2<249::aid-jbm14>3.0.co;2-x
Abstract
Three types of covalently crosslinked assemblies consisting of multiple (1) molecular layers of human serum albumin (HSA); (2) alternating layers of HSA and unfractionated heparin; and (3) alternating layers of HSA and partly depolymerized heparin fixed with one end to HSA were prepared on various surfaces. Adsorption of fibrinogen, IgG, and antithrombin (ATIII) from human citrated plasma on coated surfaces was evaluated by ELISA. Fibrinogen adsorption on coated ELISA plates was lower than that on bare polystyrene. There was no IgG adsorption on the HSA coating alone, but considerably high IgG adsorption was detected on the heparin-containing surface. The adsorption of ATIII increased with increasing heparin on the surface. The effect of multilayer coatings on platelets was tested by incubation of modified vascular prostheses with citrated blood. The most favorable interaction with platelets was observed on the HSA assembly. The interaction of platelets with the surface bearing unfractionated heparin was higher than that of the surface covered with partly depolymerized heparin. The long-term durability of the HSA–heparin coating was proven by a 21-day implantation of coated polyurethane plates in goat heart. © 2000 John Wiley & Sons, Inc. J Biomed Mater Res, 51, 249–257, 2000.Keywords
This publication has 22 references indexed in Scilit:
- Antibody networks for surface plasmon resonance immunosensorsSensors and Actuators B: Chemical, 1999
- Surface studies of albumin immobilized onto PE and PVC filmsJournal of Biomaterials Science, Polymer Edition, 1997
- Can Heparin Immobilized Surfaces Maintain Nonthrombogenic Activity During In Vivo Long-Term Implantation?Published by Ovid Technologies (Wolters Kluwer Health) ,1996
- Control of contact activation on end‐point immobilized heparin: The role of antithrombin and the specific antithrombin‐binding sequenceJournal of Biomedical Materials Research, 1995
- Adsorption of coagulation proteins from whole blood on to polymer materials: relation to platelet activationBiomaterials, 1992
- Study on the prevention of surface-induced platelet activation by albumin coatingJournal of Biomaterials Science, Polymer Edition, 1992
- Monoclonal Antibodies Against Human Antithrombin IIIHybridoma, 1991
- Haemocompatibility of segmented polyurethanes investigated in vivoBiomaterials, 1987
- A New Non-Thrombogenic Surface Prepared by Selective Covalent Binding of Heparin Via a Modified Reducing Terminal ResidueBiomaterials, Medical Devices, and Artificial Organs, 1983
- Effect of Heparin and Heparin Fractions on Platelet AggregationJCI Insight, 1980